Stablepharma

Activities: Ingredients

Trending Articles

  1. AI in pharma: the trends and future of the tech in the industry AI can enhance the efficiency and cost-effectiveness of a range of processes across the pharmaceutical industry, so S&P Global explores the current scope of the tech and its...
  2. Polyplus introduces LipidBrick for LNP formulation in mRNA therapeutics The cationic lipid broadens the scope of LNP usage in various applications from prophylactic vaccines to therapeutic and oncology applications
  3. Strides Group launches CDMO OneSource Specialty Pharma at CPHI Milan The newly integrated CDMO primarily specialises in the manufacture of biologics, drug-device combos and gelatin capsules
  4. Why use corrugated tubes in heat exchangers? There are a variety of tubular heat exchangers on the market, but for many applications corrugated tubes continue to be preferred over smooth ones. Matt Hale, International...
  5. Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Dosage Forms

Stablepharma welcomes Sir Jonathan Van-Tam to its advisory board

The company will use Prof. Van-Tam's health expertise to advance its vaccination projects
Research & Development

Dr Steven Chatfield, an advisor to the vaccines task force during the COVID pandemic, joins Stablepharma

Stablepharma is delighted to announce that Dr Steven Chatfield, an internationally recognised expert in the field of vaccines and infectious disease, has joined the advisory board
Manufacturing

Innovate UK awards Stablepharma grant to advance fridge-free vaccine

Innovate UK has awarded Stablepharma a grant to advance its lead candidate SPVX02, a fridge-free vaccine for the prevention of Tetanus and Diphtheria
Drug Delivery

Stablepharma publishes peer-reviewed article on world’s first fridge-free Tetanus diphtheria vaccine

Full recovery of vaccine potency, after 7–10 months at 45°C, was shown by complete protection against supra-lethal doses of active toxins
Research & Development

Stablepharma closes series A funding round to progress fridge-free vaccines and mRNA/LNP stabilisation technologies

Stablepharma, the fridge-free vaccine company closed their series A funding round having secured £5.2 million with lead investors Hamilton Portfolio & Oval Investments, along with CrowdCube and backing of the existing shareholders
Infection Control

Stablepharma and Bul Bio sign agreement on Tetanus diphtheria vaccine

This agreement means that Stablepharma can progress and lead full development and registration of dry, thermostable versions of the Tetadif vaccine, a WHO pre-approved vaccine for global distribution
Drug Delivery

Stablepharma demonstrates fridge-free Td vaccine tech

Td-StablevaX-M is a pre-filled disposable syringe containing dry stabilised tetanus diptheria vaccine for administration by injection following rehydration
Subscribe now